He is the Company's Chief Strategy Officer, having joined ViroStatics in 2007 following a 17-year career with Bristol-Myers Squibb where he held positions in the areas of market research (Oncology and HIV), marketing (Oncology), and medical affairs (HIV).

As vice president, immunology medical affairs, he oversaw the operation’s medical information services, medical science associates, clinical intelligence, and Phase IV clinical trials in HIV/AIDS and participated in the franchise’s strategy, portfolio planning and policy development.

He has also served on 15 protocol committees within the Adult AIDS Clinical Trials Group (ACTG). Dr. Stevens received his BS in Pharmacy and Doctor of Pharmacy (PharmD) from Purdue University.

She has been the Chief Operating Officer at ViroStatics srl since 2007. She began her career in 1993 with SNAMPROGETTI S.p.A (ENI group) as Executive Secretary for an Algerian and French engineering delegation.

In 1995, she was given responsibility for all Chinese delegations of SNAMPROGETTI and was promoted to assistant manager of customer service. Ms. Petrocchi joined RIGHT in August of 1997 as Chief Administrative Officer in Italy with responsibility for managing all organizational and public relation initiatives.

In addition to her duties for ViroStatics, Ms. Petrocchi is also a member of the RIGHT Board of Directors.

ViroStatics' Chief Business Development Officer, has over 20 years of experience in leading drug discovery, business development and licensing projects in big pharma. Most recently Dr. Chafouleas served as head of global virology licensing at Boehringer Ingelheim Canada, with worldwide corporate responsibility for partnering and alliances in the therapeutic area of virology/infectious diseases.

Earlier, Dr. Chafouleas was associate director and senior investigator in the department of biological sciences before assuming business development/licensing functions and has held adjunct faculty positions at the University of Montreal and McGill University. He has authored over 50 publications.

He has acted as ViroStatics’ Chief Medical Officer since December 2007. Dr. Pollard currently serves as the principal investigator of the immunology specialty laboratory, and chair of the AIDS Clinical Trials Group (ACTG) laboratory evaluation subcommittee. He has been a leader in HIV/AIDS research for more than twenty years and been involved in the development of new therapies for herpes viruses, hepatitis viruses and HIV.

He completed medical school education at the University of Maryland in Baltimore, and is professor of internal medicine and microbiology and chief of the division of infectious diseases at the University of California Davis. Dr. Pollard has authored over 200 publications. 

He has been Chief Legal Officer for the Company since 2009.  He has assisted technology companies for over 25 years in the areas of intellectual property, corporate matters, fundraising, and business strategy. From 1993 through 2006, he was a senior partner and a co-head of the intellectual property practice for the international law firm of Hogan & Hartson LLP, based in Washington, DC.

He has co-founded two biotech firms and has extensive experience guiding technology firms through private placements. Mr. Hautman has led negotiations for a wide variety of business transactions in the areas of biotech, IT, genomics, and life sciences. Specific commercial transactions include the structuring and negotiation of joint ventures, strategic alliances, technology transfers and licensing arrangements. He is a graduate of the University of Virginia Law School.

Dr. Giustina Casu, after the Degree in Political Science-International Relation Studies at the University of Sassari she obtained a Master Degree in Management of non profit organization and social enterprises at the University of Trento. During the professional activity she moved from the first tasks as project planner and manager for projects for inclusion, training and job insertion of migrant women, to the professional experience in communication.

In 2005 she moved to South America, in Chile, where she started to develop her skills in communication, training, and translation. She joined ViroStatics in 2010, after the experience with Porto Conte Ricerche and the Journal of Infection in Developing Countries. The previous experience in social issues and communication led her to work as Web Content Editor, translator for English and Spanish language, as well as person in charge for activities related to media relations and scientific meeting organization.

Simona Caleffi joined ViroStatics as Accounting Director in November 2008. Prior to joining the Company, she worked for Avis Rent a Car for seven years as Key Account Specialist for Management and Customer Relationship Development.

In addition to Accounting, Simona's expertise also includes the Graphic Arts.

Mr. Piras has a wealth of experience in business management and has specialized in commercial law. Paolo's expertise includes accounting, strategic planning and analysis, treasury, tax strategies, investor relations, and conducting audits.

Mr. Piras has extensive experience in business management and finance. Roberto is the founder and CEO of Kéynes, a company providing a number of services including granting credit, making strategic investments, the provision of banking facilities, and raising investment capital.